Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varda Rotter

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Molecular and Cellular Biology|February 9, 2011
SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63Chamutal Bornstein, Ran Brosh, Alina Molchadsky, et al.
Journal of Cell Science|March 20, 2012
Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signatureHilla Solomon, Yosef Buganim, Ira Kogan-Sakin, et al.
Plos One|May 1, 2013
Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon betaShalom Madar, Einav Harel, Ido Goldstein, et al.
Plos One|February 8, 2011
Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancerYuval Tabach, Ira Kogan-Sakin, Yosef Buganim, et al.
Carcinogenesis|February 24, 2009
Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1Ira Kogan-Sakin, Merav Cohen, Nicole Paland, et al.
Cancer Research|November 17, 2006
Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 inductionYosef Buganim, Eyal Kalo, Ran Brosh, et al.
Haematologica|February 24, 2022
Pseudo-mutant P53 is a unique phenotype of <i>DNMT3A</i>-mutated pre-leukemiaAmos Tuval, Yardena Brilon, Hadas Azogy, et al.
Cancer Research|April 6, 2006
hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesisIra Kogan, Naomi Goldfinger, Michael Milyavsky, et al.
Journal of Cell Science|August 18, 2012
Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen speciesEyal Kalo, Ira Kogan-Sakin, Hilla Solomon, et al.
Cancer Research|March 17, 2007
Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cellsLilach Weisz, Alexander Damalas, Michalis Liontos, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Molecular and Cellular Biology|February 9, 2011
SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63Chamutal Bornstein, Ran Brosh, Alina Molchadsky, et al.
Journal of Cell Science|March 20, 2012
Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signatureHilla Solomon, Yosef Buganim, Ira Kogan-Sakin, et al.
Plos One|May 1, 2013
Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon betaShalom Madar, Einav Harel, Ido Goldstein, et al.
Plos One|February 8, 2011
Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancerYuval Tabach, Ira Kogan-Sakin, Yosef Buganim, et al.
Carcinogenesis|February 24, 2009
Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1Ira Kogan-Sakin, Merav Cohen, Nicole Paland, et al.
Cancer Research|November 17, 2006
Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 inductionYosef Buganim, Eyal Kalo, Ran Brosh, et al.
Haematologica|February 24, 2022
Pseudo-mutant P53 is a unique phenotype of <i>DNMT3A</i>-mutated pre-leukemiaAmos Tuval, Yardena Brilon, Hadas Azogy, et al.
Cancer Research|April 6, 2006
hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesisIra Kogan, Naomi Goldfinger, Michael Milyavsky, et al.
Journal of Cell Science|August 18, 2012
Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen speciesEyal Kalo, Ira Kogan-Sakin, Hilla Solomon, et al.
Cancer Research|March 17, 2007
Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cellsLilach Weisz, Alexander Damalas, Michalis Liontos, et al.
Pageof 13